Dijous, 1 de Abril de 2021 8:04:09 Online store Business Products Documentation Contact NEW PRODUCT FOR THE TREATMENT OF ALOPECIA Technical Department History Metapharmaceutical obtains the NCF / GMP. NEW TRADE AGREEMENT Facilities Administrative Authorizations. NEW PRODUCT FOR THE TREATMENT OF ALOPECIA NigellaMed® METAPHARMACEUTICAL informs its customers that it already has the NigellaMed® product , a total extract of Nigella seeds (Nigella sativa L. or black cumin) obtained with a patented extraction process that uses supercritical CO2 and maintains all the active components of Nigella unchanged, in particular, Thymoquinone. NigellaMed® is the only Nigella extract available on the market in which the Thymoquinone titration has been defined. In addition to the already known and proven properties attributed to Nigella oil: antioxidant, antimicrobial, anticancer, analgesic and anti-inflammatory among others, there is another very interesting activity of Thymoquinone. And it is that recent studies have revealed its effectiveness in the treatment of women with alopecia who had been treated with the Nigella Sativa solution in which a significant increase in the number of hair per cm2 was observed and also an increase in the thickness of the hair. themselves. Below we detail the available containers: NigellaMed® (NIGELLA SATIVA EXTRACT) ……………… ENV / 25 GR ……………………………… € 23.25 NigellaMed® (NIGELLA SATIVA EXTRACT) …… ………… ENV / 100 GR ………………………. …… .74.39 € NigellaMed® (NIGELLA SATIVA EXTRACT) ……………… ENV / 1000 GR …………………. . ……… € 683.20 We also attach the following documentation: Technical sheet Safety sheet Monograph Article Journal of Cosmetics, Dermatological Sciences and Applications - Scientific Research We hope that the information is of interest and we remain at your disposal for any questions or queries you may have. © Copyright 2011 | Legal notice | Intranet